Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,401.50    117.00 (2.73%)
Bid:
4,382.00
Ask:
4,383.50
Spread: 1.50 (0.034%)
Market Cap: £95.31b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Publication of Final Terms

30 Oct 2025 13:34

RNS Number : 5560F
Unilever PLC
30 October 2025
 

Unilever PLC

PUBLICATION OF FINAL TERMS

 

London, 30 October 2025.

The following final terms (the "Final Terms") are available for viewing:

(i) the Final Terms dated 29 October 2025 for Unilever Capital Corporation1 EUR 850,000,000 2.875 per cent. Notes due 31 October 2032 (the "2032 Notes"); and

(ii) the Final Terms dated 29 October 2025 for Unilever Capital Corporation EUR 800,000,000 3.500 per cent. Notes due 31 October 2037 (together with the 2032 Notes, the "Notes"),

each guaranteed by Unilever PLC2 and Unilever United States, Inc.3 and issued under the $25,000,000,000 Debt Issuance Programme of Unilever Finance Netherlands B.V., Unilever PLC and Unilever Capital Corporation (the "Programme").

The Final Terms for the Notes contain the final terms of the relevant series of Notes. The Final Terms of the Notes must be read in conjunction with the Information Memorandum prepared in connection with the Programme dated 16 May 2025, as supplemented by the supplements dated 31 July 2025 and 24 October 2025 (together, the "Information Memorandum"), which together constitute a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

To view the full documents, please paste the following URL into the address bar of your browser:

https://www.unilever.com/files/unilever-capital-corporation-eur-850000000-2032-notes.pdf

https://www.unilever.com/files/unilever-capital-corporation-eur-800000000-2037-notes.pdf

A copy of the Final Terms in respect of each series will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

For further information, please contact:

Investor Relations: Investor.Relations@unilever.com

Unilever Press Office: Press-Office.London@unilever.com

This announcement does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms (when read together with the Information Memorandum) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Information Memorandum is not addressed. Prior to relying on the information contained in the Final Terms or the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are one of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

Forward-looking statements

This announcement may contain forward-looking statements within the meaning of the securities laws of certain jurisdictions, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words and terminology such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'continue', 'should', 'would be', 'seeks', or the negative of these terms and other similar expressions of future performance, results, actions or events, and their negatives, are intended to identify such forward-looking statements.

These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the "Group"). They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained in this section. Readers should not place undue reliance on forward-looking statements.

Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. Forward-looking statements are not predictions of future events. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any intention, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual events, to differ materially from those contained in any forward-looking statements. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange plc, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2024 and the Unilever Annual Report and Accounts 2024.

1Unilever Capital Corporation - LEI MYF1DAS6G5WY7PRWCU78

2Unilever PLC - LEI 549300MKFYEKVRWML317

3Unilever United States, Inc. - LEI 549300H6H8BAYLUOGZ71

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTWPGUWUUPAGWU
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20266:17 pmRNSCompletion of 2026 Share Buyback
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:13 pmRNSTotal Voting Rights
1st Jun 202610:37 amRNSDirector/PDMR Shareholding
1st Jun 202610:29 amRNSTotal Voting Rights
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
18th May 20264:35 pmRNSDirector/PDMR Shareholding
15th May 20265:45 pmRNSPublication of Information Memorandum
15th May 20265:07 pmRNSPublication of UFN Financial Statements
13th May 20263:54 pmRNSResult of AGM
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20265:49 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:08 pmRNSTotal Voting Rights
30th Apr 20267:01 amRNSShare Buy-Back Programme
30th Apr 20267:00 amRNSQ1 2026 Trading Statement
20th Apr 20261:58 pmRNSDirector/PDMR Shareholding
1st Apr 20264:42 pmRNSTotal Voting Rights
31st Mar 20263:00 pmRNSNotice of AGM
31st Mar 20261:00 pmRNSUnilever Foods and McCormick Agreement
31st Mar 20267:00 amRNSResponse to Media Speculation
20th Mar 20267:00 amRNSResponse to media speculation
6th Mar 20264:21 pmRNSDirector/PDMR Shareholding
6th Mar 20264:09 pmRNSPortfolio Update
2nd Mar 20265:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSGroup Company Secretary Change
19th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20264:38 pmRNSDirector/PDMR Shareholding
16th Feb 20264:26 pmRNSDirector/PDMR Shareholding
13th Feb 20264:57 pmRNSDirector Declaration
12th Feb 20265:11 pmRNSPublication of Supplement
12th Feb 20267:00 amRNS2025 Full Year Results
5th Feb 20264:06 pmRNSNotification of issuance of equity securities
2nd Feb 20264:14 pmRNSTotal Voting Rights
8th Jan 202610:17 amRNSTotal Voting Rights
2nd Jan 20265:21 pmRNSTotal Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSCancellation of Treasury Shares
10th Dec 202511:29 amRNSDirector/PDMR Shareholding
8th Dec 20255:51 pmRNSUpdate on Share Consolidation
8th Dec 20257:00 amRNSCompletion of demerger of Ice Cream Business
5th Dec 20257:00 amRNSDemerger of Unilever’s Ice Cream Business
3rd Dec 20252:50 pmRNSCancellation of Treasury Shares
1st Dec 20256:22 pmRNSTotal Voting Rights
19th Nov 202512:23 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20256:21 pmRNSUpdate on Demerger & Share Consolidation Timetable

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.